Cargando…

Microvessel density as a prognostic factor in esophageal squamous cell cancer patients: A meta-analysis

BACKGROUND: To date, literature has emerged that shows contradictory results about the prognostic role of microvessel density (MVD) in esophageal squamous cell cancer (ESCC). The aim of the study set out to evaluate the correlation between MVD and the prognosis of ESCC. METHODS: Identified publicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Guangzhi, Zhang, Jing, Jiang, Hai, Zhang, Nannan, Zhu, Yunjie, Deng, Yunfu, Zhou, Qinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521944/ https://www.ncbi.nlm.nih.gov/pubmed/28723804 http://dx.doi.org/10.1097/MD.0000000000007600

Ejemplares similares

Prognostic role of microvessel density in patients with glioma
por: Fan, Chaofeng, et al.
Publicado: (2019)

The combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients with resected breast cancer
por: Deng, Yunfu, et al.
Publicado: (2020)

Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Dong, Yanbo, et al.
Publicado: (2020)

Effects of clinicopathological factors on prognosis of young patients with resected breast cancer
por: Li, Wen, et al.
Publicado: (2021)

Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma
por: He, Xiao, et al.
Publicado: (2019)

Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)

Expression and prognostic value of AIM1L in esophageal squamous cell carcinoma
por: Zhou, Lu, et al.
Publicado: (2023)

Prognostic value of neutrophil-to-lymphocyte ratio in peripheral blood and pathological tissue in patients with esophageal squamous cell carcinoma
por: Guo, Quanquan, et al.
Publicado: (2020)

Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis
por: Zhou, Rui, et al.
Publicado: (2020)

Real-world treatment patterns and survival for locally advanced esophageal squamous cell carcinoma
por: Luo, Hua-Chun, et al.
Publicado: (2023)

Facial flushing after alcohol consumption and the risk of cancer: A meta-analysis
por: Zhang, Jing, et al.
Publicado: (2017)

Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma
por: Zhang, Guoqing, et al.
Publicado: (2019)

High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma
por: Han, Na, et al.
Publicado: (2021)

Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
por: Yang, Xiyue, et al.
Publicado: (2021)

High FN1 expression is associated with poor survival in esophageal squamous cell carcinoma
por: Ma, Junliang, et al.
Publicado: (2022)

Efficacy of albumin-bound paclitaxel combined with nedaplatin in neoadjuvant therapy for esophageal squamous cell carcinoma: A single-center retrospective observational study
por: Chen, Jiakuan, et al.
Publicado: (2023)

Effects of preoperative radiotherapy on survival of patients with stage II and III esophageal squamous cell carcinoma: A population-based study
por: Dong, Jing, et al.
Publicado: (2021)

A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinoma
por: Sun, Lijun, et al.
Publicado: (2023)

Lymphopenia Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2014)

High expression of cytokeratin CAM5.2 in esophageal squamous cell carcinoma is associated with poor prognosis
por: He, Shujin, et al.
Publicado: (2019)

The clinicopathological features and prognostic factors of gastric squamous cell carcinoma
por: Dong, Caixia, et al.
Publicado: (2016)

Postoperative radiotherapy for the young–old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience
por: Ding, Wei, et al.
Publicado: (2020)

The role of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 in esophageal squamous cell carcinoma
por: Bao, Junhui, et al.
Publicado: (2020)

Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy: A retrospective analysis from a single cancer institute
por: Jing, Wang, et al.
Publicado: (2016)

Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan
por: Chen, Hui-Shan, et al.
Publicado: (2016)

Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma
por: Yan, Li, et al.
Publicado: (2020)

The prognostic significance of prognostic nutritional index in gastrointestinal stromal tumors: A systematic review and meta-analysis
por: Li, Zhenjie, et al.
Publicado: (2022)

Polymorphisms of matrix metalloproteinases affect the susceptibility of esophageal cancer: Evidence from 20412 subjects, systematic review and updated meta-analysis
por: Chen, Hai, et al.
Publicado: (2021)

Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches
por: Li, Hao, et al.
Publicado: (2015)

Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer
por: Hou, Jun, et al.
Publicado: (2022)

Intensity-modulated radiotherapy with more than 60 Gy improved the survival of inoperable patients with locally advanced esophageal squamous cell carcinoma: A population-based real-world study
por: Zhang, Wei, et al.
Publicado: (2022)

Epstein–Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis
por: Zhang, Jing, et al.
Publicado: (2016)

The association between statin use and prognosis in esophageal cancer patients: A meta-analysis
por: Lv, Jing, et al.
Publicado: (2023)

A case report of immune checkpoint inhibitor nivolumab combined with anti-angiogenesis agent anlotinib for advanced esophageal squamous cell carcinoma
por: Tang, Yong, et al.
Publicado: (2019)

Prognostic value of radiologically determined sarcopenia prior to treatment in urologic tumors: A meta-analysis
por: Li, Jialin, et al.
Publicado: (2019)

High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma
por: Oh, Dongryul, et al.
Publicado: (2016)

The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma
por: Zhao, Zheng, et al.
Publicado: (2023)

Molecular subtyping and prognostic risk characterization of head and neck squamous cell carcinoma based on lysosome-related genes
por: Zhang, Aichun, et al.
Publicado: (2023)

Pan-cancer analysis of aldolase B gene as a novel prognostic biomarker for human cancers
por: Zhao, Nannan, et al.
Publicado: (2023)

Hot food and beverage consumption and the risk of esophageal squamous cell carcinoma: A case-control study in a northwest area in China
por: Tai, Wei-Ping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jkpme8i0gpqgsl6avfoltgmtqm